Scotts Miracle-Gro Company (The

Valuation Analysis

About the Company

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. The company provides lawn care products, comprising lawn fertilizers, clover and grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. It also offers hydroponic products that help users to grow plants, flowers, and vegetables

Scotts Miracle-Gro Company (The Stock at a Glance

Scotts Miracle-Gro Company (The (SMG) is currently trading at $61.67 with a market capitalization of $3.6B. The trailing P/E ratio stands at 17.72x, with a forward P/E of 13.13x. The 52-week range spans from $52.00 to $72.35; the current price is 14.8% below the yearly high. Year-over-year revenue growth stands at +5.0%. The net profit margin stands at 3.19%.

💰 Dividend

Scotts Miracle-Gro Company (The pays an annual dividend of $2.64 per share, representing a yield of 4.28%. The payout ratio stands at 75.86%.

📊 Analyst Rating

6 analysts rate Scotts Miracle-Gro Company (The (SMG) on consensus: Buy. The average price target is $72.67, implying +17.83% from the current price. Analyst price targets range from $63.00 to $80.00.

Scotts Miracle-Gro Company (The: The Investment Case in Detail

Scotts Miracle-Gro Company (The (SMG) operates in the Basic Materials — specifically Agricultural Inputs — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Wall Street consensus sits at Buy with an average price target implying roughly 17.83% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

With a net margin of just 3.19%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. With a beta near 1.83, the share price moves sharply more than the broader market — drawdowns in market corrections can be unusually severe and require strong nerves. Short interest sits at 12.13% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valuation in Context

With a PEG ratio of 0.85, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The forward P/E of 13.13x is meaningfully below the trailing 17.72x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to above-average price swings, elevated short interest (12.13%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Scotts Miracle-Gro Company (The?

Compare top-rated brokers — low fees, trusted providers, fully regulated.